Vaccine Safety

Control is crucial — WHAT THE TRUCK?!?

Health is something Chad Brueck, president of expedited solutions at CRST, knows is a valuable asset. He is a marathon runner, fitness enthusiast and a newly minted group fitness instructor and that discipline translates into good business practices.

Brueck handles truckload hauling of pharmaceutical products with CRST and has seen the industry shift during the COVID-19 pandemic. Brueck said CRST is focused on working with each of its clients to deliver products in the safest, most controlled...

https://www.freightwaves.com/news/control-is-crucial-what-the-truck

AstraZeneca COVID Vaccine Safety Report on Participant’s Illness

AstraZeneca's Oxford vaccine trial to resume, the university says

CNN has obtained an internal safety report by pharmaceutical giant AstraZeneca that sheds light on the neurological condition suffered by one of the participants in its coronavirus vaccine clinical trial, says an article published on their website.

What’s in the report?The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5.
Four days later,...

https://mfame.guru/astrazeneca-covid-vaccine-safety-report-on-participants-illness/

Johnson & Johnson COVID Vaccine 99% Efficient in Single Dose

Shares of Johnson & Johnson rally after opioid fine

There is some good news on Johnson & Johnson’s coronavirus vaccine as trials show even one dose of their vaccine is effective against the virus, reports CNN.

What the trial result shows?
  • Early results from a Phase 1/2a clinical trial show it was well tolerated and even one dose appeared to produce a strong immune response in almost all of the 800 participants.
  • The trial included two age groups: 18- to 55-year-olds and 65 and older, and looked at the safety and side effects of two different doses.

https://mfame.guru/johnson-johnson-covid-vaccine-99-efficient-in-single-dose/

COVID19 Vaccinations To Start by Nov-Dec As Winter Nears

Fauci cautions that a Covid-19 vaccine won't eliminate the need for masks and public health measures

According to a CNN report, Covid-19 vaccinations could start as early as November or December, Dr. Anthony Fauci, the nation’s leading infectious disease expert, said Friday.

Fauci’s comments come as the US passed 7 million confirmed cases of Covid-19, according to data from Johns Hopkins University. More than 203,000 people have died.

Despite the prediction, Fauci says it could still be a while until everything returns to pre-Covid normalcy.

Return To Normalcy By 2021 Third Quarter
“By the time...

https://mfame.guru/covid19-vaccinations-to-start-by-nov-dec-as-winter-nears/

Pfizer Betting on Early COVID19 Vaccine Win, Protocol Shows

Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters that describe how the trial is being run.

Results By End of October?

In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany’s BioNTech SE, is safe and effective. If the vaccine is shown to work by then, Pfizer has said it would...

https://mfame.guru/pfizer-betting-on-early-covid19-vaccine-win-protocol-shows/

Global Faith in Chinese COVID19 Vaccine Prompts Mass Inoculation

 In a  major development, China is inoculating tens of thousands of its citizens with experimental coronavirus vaccines and attracting international interest in their development, despite expert concerns over the safety of drugs that have not completed standard testing, reports Reuters.

Emergency Vaccine Use

China launched a vaccine emergency use program in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and...

https://mfame.guru/global-faith-in-chinese-covid19-vaccine-prompts-mass-inoculation/

Pfizer COVID19 Vaccine Trial Blueprint Shows Mild Side Effects

According to a Reuters report, Pfizer Inc said on Tuesday that their vaccine trial participants were showing mild-to-moderate side effects when given either the company’s experimental coronavirus vaccine or a placebo in an ongoing late-stage study.

Over 12,000 study participants had received a second dose of the vaccine, Pfizer executives said on an investor conference call.

Scrutinizing Safety 

The company has enrolled more than 29,000 people in its 44,000-volunteer trial to test the experimental...

https://mfame.guru/pfizer-released-covid19-vaccine-trial-blueprint-shows-mild-side-effects/

Oxford Resumes AstraZeneca COVID19 Vaccine Trial

Rules and guidance meeting up - 11 Sept
  • The oxford vaccine trial is set to resume after being cleared by the UK Health department
  • The trials were stopped earlier this month when a participant developed spinal cord problems
  • The company has refused to give details of the participant but has assured that an independent investigation is being done.
  • The investigation is done to understand whether the illness developed due to the vaccine or other issues
  • The participant hasn’t disclosed whether she had this condition before.
  • Meanwhile,...

https://mfame.guru/oxford-resumes-astrazeneca-covid19-vaccine-trial/

No Compromise on Vaccine Safety, Says WHO After COVID19 Vaccine Trial Stoppage

According to a Reuters report, the World Health Organization has reiterated the importance of vaccine safety after the oxford vaccine trial was stopped due to participant falling ill.

Safety of a prospective COVID-19 vaccine comes “first and foremost”, the World Health Organization’s chief scientist said on Wednesday, as a trial of a leading candidate from AstraZeneca was paused due to concerns over side effects.

The rollout of an effective vaccine is seen as a crucial step in helping battered...

https://mfame.guru/no-compromise-on-vaccine-safety-says-who-after-covid19-vaccine-trial-stoppage/

Russian COVID Vaccine ‘Sputnik V’ Proves Safety in Lancet Study

A handout photo released by Russian Healthcare ministry (Minzdrav) shows containers with a newly registered vaccine against coronavirus in Moscow, Russia.

According to a CNN report,  Covid-19 vaccine developed and tested in Russia generated neutralizing antibodies in dozens of study subjects, and while the vaccine often caused side effects such as fever, those side effects were mostly mild, says data published Friday in the medical journal The Lancet.

Russia drew criticism when it announced the world’s first approved coronavirus vaccine for public use in August — even before crucial Phase 3 trials had been completed.

Results Show Natural Infection...

https://mfame.guru/russian-covid-vaccine-sputnik-v-proves-safety-in-lancet-study/

+ More
Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.
icon
By subscribing, you agree with our privacy policy and our terms of service.